Experimental evidence has shown that ARBs can prevent stroke by blocking the local angiotensin II type 1 receptor and simultaneously allowing angiotensin II to stimulate unoccupied angiotensin II type 2 receptors, increasing local blood flow to the brain and preventing the death of injured cells in ischemic areas19. This evidence concerns the gene AGT and Stroke.